Team Leader
Lisa Walker
Clinician Investigator, NeuroscienceWhat We Do
- cognitive fatigability
- cognitive rehabilitation
- the impact of exercise on cognition
- needs of the 2SLGBTQIA+ MS population
Past areas of interest have included:
- the impact of stem-cell therapies on cognition
- the relationship between cognition and biomarkers of disease (e.g. imaging, sNfL)
- the assessment of cognition (e.g. psychometrics)
Our lab consists of a number of dedicated health professionals who are passionate about what we do. It is our collective goal to improve the quality of life in those people with MS whom we serve.
Visit the Lab Website
Research Activities
Selected Publications
Donkers, S.J., Berscheid, M., Bayley, M., Bruno, T.R., Pilutti, L., Simpson, R., Smyth, P., Walker, L.A.S., Knox, K.B., on behalf of the AGREE Working Group of the Canadian MS Rehabilitation Knowledge Mobilization Network (2025). Quality and scope of published international guidelines for multiple sclerosis care: AGREE II Appraisal. NeuroRehabilitation, DOI: 10.1177/10538135251387611
Walker, L.A.S., Finlayson, M., Cameron, J., Donkers, S.J., Knox, K., Mayo, N., Ploughman, M., Canlas, K., Jacksch, M., Liu, S. & Pilutti, L. on behalf of MSCanRehab (2025). A conceptual approach to comprehensive interdisciplinary cognitive rehabilitation: A description using the TIDieR-Rehab Framework. Multiple Sclerosis and Related Disorders, 104, 106783. (published on-line 2 October 2025). https://doi.org/10.1016/j.msard.2025.106783
Craft, C.L., Islam, T., Berard, J.A. & Walker, L.A.S. (2025). Subjective cognitive fatigability is associated with worse patient-reported physical disability in multiple sclerosis. Multiple Sclerosis and Related Disorders. 106720 (published on-line 2 September 2025). https://doi.org/10.1016/j.msard.2025.106720
Scandiffio, J., Feng, G., Sureshkumar, A., Senthilnathan, V., Langer, L.K., Bromberg, M., Babineau, J., Donkers, S., Knox, K., Bruno, T., Walker, L.A.S., Bayley, M.T. & Simpson, R. (2025). Effects of psychological therapies in people with multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials. Journal of Neurology, 272:584. doi:10.1007/s00415-025-13315-6Donkers, S. J. & Walker, L.A.S. (2025). An interdisciplinary approach is necessary in the treatment of cognitive decline in MS – Yes. Multiple Sclerosis Journal, 31(3): 257-259. https://doi.org/10.1177/13524585251315344
Edwards T, Chaves AR, Awadia Z, Ludgate J, Peters A, Walker LAS, Pilutti LA. (2025). Feasibility of Aerobic Exercise in People with Advanced Multiple Sclerosis: Characterizing Acute Responses to Inform Exercise Prescription. International Journal of Multiple Sclerosis Care, 27:218-228. doi:10.7224/1537-2073.2024-063
Islam, T., Pumphrey, J.D., Bowman, M., Berard, J.A., Bearnes, R., Pham, T. & Walker, L.A.S. (2025). Implementation of Cognition, Fatigue, and Mental Health Screening at a Canadian Multiple Sclerosis Centre: A Quality Improvement Initiative. International Journal of Multiple Sclerosis Care, 27, 195-199. doi:10.7224/1537-2073.2024-096
Walker, L.A.S., Berard, J.A., Islam, T., Pilutti, L.A., Morrow, S.A. & Finlayson, M. (2022). Development of a behavioural intervention for cognitive fatigability in multiple sclerosis: Protocol for a pilot and feasibility study. Frontiers in Rehabilitation Sciences, 3:999266. (published on-line 16 November 2022). https://www.frontiersin.org/articles/10.3389/fresc.2022.999266/full
Berard, J.A. & Walker, L.A.S. (2022). Validity and Sensitivity of Canadian Normative Data for the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) Battery. Multiple Sclerosis and Related Disorders, 63, 103865. (published on-line 10 May 2022). https://doi.org/10.1016/j.msard.2022.103865
Berard, J.A., Freedman, M.S., Marrie, R.A., Marriott, J.J., Atkins, H.L., Szwajcer, D., Courtman, D.W., Thebault, S. & Walker, L.A.S. (2022). The impact of mesenchymal stem cell therapy on cognition in individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders, 61, 1-8, 103779 (published on-line 27 March 2022). https://doi.org/10.1016/j.msard.2022.103779
Berard, J.A. & Walker, L.A.S. (2021). Increasing the clinical utility of the Paced Auditory Serial Addition Test: Normative data for standard performance, dyad and cognitive fatigability scoring. Cognitive and Behavioral Neurology, 34(2), 107-116. https://doi:10.1097/WNN.0000000000000268. PMID: 34074865
Atkins, H.L., Bowman, M., Allan, D., Anstee, G., Arnold, D.L., Bar-Or, A., Bence-Bruckler, I., Birch, P., Bredeson, C., Chen, J., Fergusson, D., Halpenny, M., Hamelin, L., Heubsch, L., Hutton, B., Laneuville, P., Lapierre, Y., Lee, H., Martin, L., McDiarmid, S., O’Connor, P., Ramsay, T., Sabloff, M., Walker, L.A.S. & Freedman, M.S. (2016; 6-12 Aug). Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial. The Lancet, 388 (10044), 576-585, (online 9 June 2016) http://dx.doi.org/10.1016/S0140-6736(16)30169-6 PMID: 27291994